These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 20158614

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.
    McDonagh SC, Lee J, Izzo A, Brubaker PL.
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017
    [Abstract] [Full Text] [Related]

  • 6. Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.
    Baldassano S, Wang GD, Mulè F, Wood JD.
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb 01; 302(3):G352-8. PubMed ID: 22075777
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms underlying the prokinetic effects of endogenous glucagon-like peptide-1 in the rat proximal colon.
    Nakamori H, Iida K, Hashitani H.
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec 01; 321(6):G617-G627. PubMed ID: 34643099
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
    Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellström PM.
    J Clin Invest; 1998 Aug 15; 102(4):764-74. PubMed ID: 9710445
    [Abstract] [Full Text] [Related]

  • 9. Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release.
    Amato A, Baldassano S, Serio R, Mulè F.
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar 15; 296(3):G678-84. PubMed ID: 19109404
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of expression and function of the glucagon-like peptide-1 receptor in colonic smooth muscle.
    May AT, Crowe MS, Blakeney BA, Mahavadi S, Wang H, Grider JR, Murthy KS.
    Peptides; 2019 Feb 15; 112():48-55. PubMed ID: 30508636
    [Abstract] [Full Text] [Related]

  • 12. Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus.
    Garella R, Idrizaj E, Traini C, Squecco R, Vannucchi MG, Baccari MC.
    World J Gastroenterol; 2017 Oct 28; 23(40):7211-7220. PubMed ID: 29142468
    [Abstract] [Full Text] [Related]

  • 13. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH, Inoue T, Higashiyama M, Guth PH, Engel E, Kaunitz JD, Akiba Y.
    J Pharmacol Exp Ther; 2011 Nov 28; 339(2):464-73. PubMed ID: 21846840
    [Abstract] [Full Text] [Related]

  • 14. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
    Hayes MR, Kanoski SE, De Jonghe BC, Leichner TM, Alhadeff AL, Fortin SM, Arnold M, Langhans W, Grill HJ.
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov 28; 301(5):R1479-85. PubMed ID: 21849636
    [Abstract] [Full Text] [Related]

  • 15. Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans.
    Halim MA, Degerblad M, Sundbom M, Karlbom U, Holst JJ, Webb DL, Hellström PM.
    J Clin Endocrinol Metab; 2018 Feb 01; 103(2):575-585. PubMed ID: 29177486
    [Abstract] [Full Text] [Related]

  • 16. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
    Bucinskaite V, Tolessa T, Pedersen J, Rydqvist B, Zerihun L, Holst JJ, Hellström PM.
    Neurogastroenterol Motil; 2009 Sep 01; 21(9):978-e78. PubMed ID: 19453518
    [Abstract] [Full Text] [Related]

  • 17. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Diabetes; 2004 Sep 01; 53(9):2492-500. PubMed ID: 15331566
    [Abstract] [Full Text] [Related]

  • 18. Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways.
    Farkas I, Vastagh C, Farkas E, Bálint F, Skrapits K, Hrabovszky E, Fekete C, Liposits Z.
    Front Cell Neurosci; 2016 Sep 01; 10():214. PubMed ID: 27672360
    [Abstract] [Full Text] [Related]

  • 19. Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions.
    Holmes GM, Browning KN, Tong M, Qualls-Creekmore E, Travagli RA.
    J Physiol; 2009 Oct 01; 587(Pt 19):4749-59. PubMed ID: 19675064
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus.
    Pini A, Garella R, Idrizaj E, Calosi L, Baccari MC, Vannucchi MG.
    Neurogastroenterol Motil; 2016 Feb 01; 28(2):206-16. PubMed ID: 26547262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.